AI-driven Clinical Decision Support to Reduce Hospital-Acquired Venous Thromboembolism: Study Protocol for the VTE-AI Randomized Trial.
Launched by VANDERBILT UNIVERSITY MEDICAL CENTER · Apr 15, 2025
Trial Information
Current as of August 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The VTE-AI Randomized Trial is studying a new tool that uses artificial intelligence (AI) to help prevent blood clots that can occur while patients are in the hospital. These blood clots, known as hospital-acquired venous thromboembolism (HA-VTE), can lead to serious health issues and even death, making them a significant concern for patients and healthcare providers. The trial aims to find out if the AI tool can better identify patients at risk for these blood clots compared to the traditional method currently used by doctors, which requires them to manually calculate a risk score.
Eligible participants for this study include adults admitted to one of several Vanderbilt hospitals. If you are selected to participate, you will be randomly assigned to either use the AI tool or continue with the standard method for preventing blood clots. The AI tool will suggest preventative measures for patients who need them, helping to ensure that more people receive the care they need to avoid complications from blood clots. This study is important because it could lead to better prevention strategies and improve patient safety in hospitals.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Inpatient admission to Vanderbilt Adult Hospital, Vanderbilt Tullahoma Harton Hospital, Vanderbilt Bedford County Hospital, or Vanderbilt Wilson County Hospital
- Exclusion Criteria:
- • None
About Vanderbilt University Medical Center
Vanderbilt University Medical Center (VUMC) is a leading academic medical center located in Nashville, Tennessee, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, VUMC integrates cutting-edge scientific inquiry with patient-centered care, supporting a diverse array of studies aimed at enhancing medical knowledge and improving treatment outcomes. With a robust infrastructure and a multidisciplinary team of experts, VUMC fosters collaboration across various fields, ensuring the highest standards of safety and ethical considerations in its research endeavors. Through its dedication to medical discovery and education, VUMC plays a pivotal role in shaping the future of medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported